Amyotrophic Lateral Sclerosis (ALS) Research, Treatment, and Assistance Act of 1997
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jun 23, 1997)
Amyotrophic Lateral Sclerosis (ALS) Research, Treatment, and Assistance Act of 1997 - Amends title II (Old Age, Survivors and Disability Insurance) of the Social Security Act (SSA) to provide for a waiver of the 24-month waiting period for Medicare coverage for individuals disabled by amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's Disease.
Amends SSA title XVIII (Medicare) to provide for Medicare coverage of any drug approved by the Food and Drug Administration for use in the treatment or alleviation of ALS-related symptoms.
Authorizes appropriations, in addition to any already available, for ALS research through the National Institutes of Health.
What just happenedJun 26, 1997
Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.
Who’s behind it
- Introduced in HouseJun 23, 1997
- Jun 26, 1997CommitteeH11000
Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.
Health and Environment Subcommittee - Jun 25, 1997CommitteeH11000
Referred to the Subcommittee on Health.
Health Subcommittee - Jun 23, 1997IntroReferralH11100
Referred to House Commerce
Energy and Commerce Committee - Jun 23, 1997IntroReferralH11100-A
Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Jun 23, 1997IntroReferralH11100
Referred to House Ways and Means
Ways and Means Committee - Jun 23, 1997IntroReferralB00100
Sponsor introductory remarks on measure. (CR E1298)
- Jun 23, 1997IntroReferralIntro-H
Introduced in House
- Jun 23, 1997IntroReferral1000
Introduced in House